 |
市場調查報告書
商品編碼
1136966
乾燥症(修格蘭氏症候群)市場:藥物(抗瘧疾哇林藥，膽鹼促效劑，皮質類固醇，其他)，各類型，各流通管道，各地區-規模，佔有率，展望，機會分析，2022年～2030年Sjogren's Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others ), by type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
市場動態
預計乾燥綜合徵患病率的增加將在預測期內推動市場增長。
本調查的主要特徵
- 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球乾燥症(修格蘭氏症候群)市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
- 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
- 同時並提供市場推動因素和限制、機會、新產品發佈或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
- 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球乾燥症(修格蘭氏症候群)市場的主要參與者之企業簡介。
- 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
- 全球乾燥症(修格蘭氏症候群)市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以透過全球乾燥症(修格蘭氏症候群)市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。
目錄
第1章 調查目的與前提條件
- 調查目的
- 前提條件
- 簡稱的說明
第2章 市場展望
- 報告內容
- 市場定義和範圍
- 摘要整理
- 市場明細:藥物
- 市場明細:各類型
- 市場明細:各流通管道
- 市場明細，各地區
- 連貫機遇地圖(COM)
第3章 市場動態，法規，趨勢分析
- 促進因素
- 阻礙因素
- 商機
- 影響分析
- 主要的發展策略
- M&A情景
- 市場趨勢
- 品牌分析
- 法規方案
- PEST分析
- 定價分析
- 開發平台分析
第4章 乾燥症(修格蘭氏症候群)的全球市場:冠狀病毒(COVID-19)疫情的影響
- COVID-19流行病學的特徵
- 製造的影響
- 製造的影響
第5章 乾燥症(修格蘭氏症候群)的全球市場:各藥物，2017年～2030年
- 抗瘧疾藥哇林系
- 膽鹼工作性促效劑
- 皮質類固醇
- 其他(疼痛緩和藥，後期治療藥)
第6章 乾燥症(修格蘭氏症候群)的全球市場:各類型，2017年～2030年
- 一次性
- 二次性
第7章 乾燥症(修格蘭氏症候群)的全球市場:各流通管道，2017年～2030年
- 醫院藥局
- 零售藥局
- 線上藥局
第8章 乾燥症(修格蘭氏症候群)的全球市場:各地區，2017年～2030年
- 北美
- 美國
- 加拿大
- 南美
- 巴西
- 墨西哥
- 阿根廷
- 其他的南美地區
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他的歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東地區
- GCC
- 以色列
- 其他的中東地區
- 非洲
- 南非
- 中非
- 北非
第9章 競爭情形
- Competitive Snapshot
- ADVANZ Pharma
- Type Portfolio
- Bristol Myers Squibb
- Type Portfolio
- Daiichi Sankyo
- Type Portfolio
- GlaxoSmithKline
- Type Portfolio
- Novartis/MorphoSys
- Type Portfolio
- RemeGen
- Type Portfolio
- Resolve Therapeutics
- Type Portfolio
- TearSolutions
- Type Portfolio
- VIELABIO
- Type Portfolio
- Otsuka Pharmaceutical Co., Ltd.
- Type Portfolio
- Bridge Pharma Inc.
- Type Portfolio
第10章 章節
- 參考文獻
- 調查手法
簡介目錄
Product Code: CMI5210
Sjogren's syndrome is systematic autoimmune disorder which effect the entire body, along with complication such as, chronic pain, major organ involvement, profound fatigue, neuropathies and Sjogren's syndrome zmphomas.
For the treatment of Sjogren's syndrome different medication such as methotrexate available to manage the syndrome. Currently no single medication has been conclusively proven to treat the progression of Sjogren's.
Antimalarial Quinolines, Cholinergic Agonists and Corticosteroids are the prescription drug used for the treatment of Sjogren's.
Market Dynamics
Increasing prevalence of Sjogren's syndrome is expected to drive the market growth during the forecast period.
For instance, according to the Sjogren's Foundation 2021, around 3 to 4 million people in the U.S. suffer from Sjogren's syndrome which is as common as rheumatoid arthritis (RA), and three times as common as systemic lupus erythematosus (SLE).
Key features of the study:
- This report provides an in-depth analysis of the global sjogren's syndrome market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sjogren's syndrome Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include ADVANZ Pharma, Bristol Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Novartis/MorphoSys, RemeGen, Resolve Therapeutics, Tear Solutions, VIELABIO, Otsuka Pharmaceutical Co., Ltd., and Bridge Pharma Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sjogren's syndrome Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sjogren's syndrome Market
Detailed Segmentation:
- Global Sjogren's Syndrome Market, By Drug:
- Antimalarial Quinolines
- Cholinergic Agonists
- Corticosteroids
- Others (Pain Relief Medication and late phase drug)
- Global Sjogren's Syndrome Market, By Type:
- Primary
- Secondary
- Global Sjogren's Syndrome Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Global Sjogren's Syndrome Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest Of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- ADVANZ Pharma *
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb
- Daiichi Sankyo
- GlaxoSmithKline
- Novartis/MorphoSys
- RemeGen
- Resolve Therapeutics
- TearSolutions
- VIELABIO
- Otsuka Pharmaceutical Co., Ltd.
- Bridge Pharma Inc.
- ADVANZ Pharma *
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Development Strategies
- Mergers And Acquisition Scenario
- Market Trends
- Brand Analysis
- Regulatory Scenario
- PEST Analysis
- Pricing Analysis
- Pipeline Analysis
4. Global Sjogren's syndrome Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact on Manufacturing
- Impact on Manufacturing
5. Global Sjogren's syndrome Market, By Drug, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Antimalarial Quinolines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Cholinergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Others (Pain Relief Medication and late phase drug)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
6. Global Sjogren's syndrome Market, By Type, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Primary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Secondary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
7. Global Sjogren's syndrome Market, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
8. Global Sjogren's syndrome Market, By Region, 2017 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- North America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Competitive Snapshot
- ADVANZ Pharma *
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Daiichi Sankyo
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis/MorphoSys
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RemeGen
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Resolve Therapeutics
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- TearSolutions
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- VIELABIO
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bridge Pharma Inc.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
2023 年至 2030 年干燥綜合徵的全球市場
乾燥綜合症全球市場規模研究與預測，按類型/應用/分銷渠道，區域分析，2022-2029 年
乾燥症(修格蘭氏症候群)的全球市場:2022年～2028年